BioNTech SE (BNTX)
BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls
American depositary receipts (ADRs) of BioNTech (BNTX) fell Monday after the COVID-19 vaccine maker's second-quarter loss quadrupled on falling demand for the shots, and as it ended an agreement with biotech firm Genmab to develop a lung cancer drug.
BioNTech's stock slides 4% after earnings fall short of estimates as COVID vaccine falls slide
BioNTech SE's stock BNTX, +1.65% fell 4% early Monday, after the company's second-quarter earnings fell short of estimates amid a continued slide in sales of its COVID-19 vaccine. The company had a net loss of 807.8 million euros ($883.5 million), or $3.36 a share, for the quarter, wider than the los of EUR109.4 million, or 79 cents a share, posted in the year-earlier period.
BioNTech widens loss to 807.8 mln euro in second quarter
Losses at Germany's BioNTech quadrupled year-on-year in the second quarter, the company said on Monday, as it banks on a strategy shift towards new cancer treatments following a sharp drop-off in sales of its COVID-19 vaccine.
BioNTech's cancer drug meets primary endpoint in Phase 2 trial
COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German company said on Tuesday.
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug Administration has placed a partial clinical hold on an early-stage study of its experimental cancer drug.
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
COVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against infectious diseases to build a production network in African countries for messenger-RNA based shots.
Why Vaccine Stocks Rallied This Week
H5N1 bird flu was detected this week in Michigan and Australia. It's the first detection in humans since March, when news of an outbreak in cattle emerged.
